Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | BTG3 |
| Upstream (Parents) |
|---|
| (<<) DSE → BTG3 |
| (<<) TFEC → BTG3 |
| (<<) CXADR → BTG3 |
| (<<) FCER1G → BTG3 |
| (<<) CLEC2B → BTG3 |
| (<<) TYROBP → BTG3 |
| (<<) FLI1 → BTG3 |
| Downstream (Children) |
|---|
| BTG3 → ZBTB10 (>>) |
| BTG3 → CXADR (>>) |
| BTG3 → ZNF671 (>>) |
| BTG3 → RAB33A (>>) |
| BTG3 → TAF4 (>>) |
| BTG3 → ERGIC3 (>>) |
| BTG3 → PSG5 (>>) |
| BTG3 → FBXO21 (>>) |
| BTG3 → FRMD1 (>>) |
| BTG3 → BAIAP3 (>>) |
| BTG3 → BZRAP1 (>>) |
| BTG3 → OR10H3 (>>) |
| BTG3 → HIVEP3 (>>) |
